Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

This morning's movement says it all really we at bargain basement prices and the world knows it. Exciting close to the week will see the bid close at 33p+

We have much ground to make up....and much news to hear from OXB. All sorts has been going on these past 6-8 weeks and I mean ALL SORTS!

Someone said we are entering the sunshine. Well not wrong there, though not exactly difficult to have predicted. Yesterday I was well over 250-300K long again.

I still have my bid concerns. IMO OXB will be highly vulnerable prior to their first major TroVax P111 out-licence partner deal. Remember, OXB have signalled that a substantial proportion of the placement funds will go towards the RCC trial...thing is a partner is STILL being sort so that would certainly allow placing $$ to go towards ProSavin's clinical progression/programme.

As we all recognise the new and substantial funding massively improves our negotiating position for TroVax...and ProSavin ;o). Potential partners are between a rock and a hard place. Its decision time for them now...and I mean right now! (all IMHO) If they wait until H2 06 they'll be paying way more as there will be substantially more P11 CD8 and survival efficacy data, and P111 will be v close to, if not, underway...